Donna McMorrow

803 total citations
42 papers, 576 citations indexed

About

Donna McMorrow is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Rheumatology. According to data from OpenAlex, Donna McMorrow has authored 42 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 9 papers in Rheumatology. Recurrent topics in Donna McMorrow's work include Asthma and respiratory diseases (9 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Biosimilars and Bioanalytical Methods (6 papers). Donna McMorrow is often cited by papers focused on Asthma and respiratory diseases (9 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Biosimilars and Bioanalytical Methods (6 papers). Donna McMorrow collaborates with scholars based in United States, United Kingdom and Switzerland. Donna McMorrow's co-authors include Stephen S. Johnston, Kelly Krohn, Joseph M. Lane, Daniel H. Solomon, Natalie Boytsov, Machaon Bonafede, Pamela Landsman‐Blumberg, Elizabeth Packnett, Chieh-I Chen and Jared Silver and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Donna McMorrow

38 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna McMorrow United States 13 228 206 137 77 77 42 576
P. Aguado Spain 13 219 1.0× 88 0.4× 111 0.8× 48 0.6× 57 0.7× 51 595
Nianwen Shi United States 14 96 0.4× 152 0.7× 85 0.6× 194 2.5× 80 1.0× 35 631
M.L. te Winkel Netherlands 15 199 0.9× 96 0.5× 203 1.5× 18 0.2× 156 2.0× 25 764
Axel Svedbom Sweden 19 353 1.5× 347 1.7× 100 0.7× 130 1.7× 85 1.1× 55 981
J. Timothy Harrington United States 13 409 1.8× 289 1.4× 166 1.2× 98 1.3× 46 0.6× 27 719
Michele Intorcia Switzerland 14 257 1.1× 95 0.5× 317 2.3× 123 1.6× 211 2.7× 39 871
L. Pericleous Canada 10 82 0.4× 114 0.6× 46 0.3× 33 0.4× 33 0.4× 18 328
Ora Yadin United States 13 46 0.2× 108 0.5× 70 0.5× 25 0.3× 45 0.6× 31 874
Rebecca Manno United States 14 52 0.2× 85 0.4× 322 2.4× 90 1.2× 45 0.6× 34 984
Michael Schwarz-Eywill Germany 12 53 0.2× 48 0.2× 95 0.7× 25 0.3× 97 1.3× 31 550

Countries citing papers authored by Donna McMorrow

Since Specialization
Citations

This map shows the geographic impact of Donna McMorrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna McMorrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna McMorrow more than expected).

Fields of papers citing papers by Donna McMorrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna McMorrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna McMorrow. The network helps show where Donna McMorrow may publish in the future.

Co-authorship network of co-authors of Donna McMorrow

This figure shows the co-authorship network connecting the top 25 collaborators of Donna McMorrow. A scholar is included among the top collaborators of Donna McMorrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna McMorrow. Donna McMorrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lozama, Anthony, Barnabie Agatep, Donna McMorrow, et al.. (2025). LIPOPROTEIN(A) TESTING AND IMPACT: A LARGE POOLED ANALYSIS OF PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASES. Journal of the American College of Cardiology. 85(12). 386–386. 1 indexed citations
2.
Lozama, Anthony, Barnabie Agatep, Iman Mohammadi, et al.. (2025). Elevated lipoprotein(a) in patients with premature atherosclerotic cardiovascular disease: Insights from a large US real-world cohort. Journal of clinical lipidology. 1 indexed citations
3.
4.
Clarke, Callisia N., Paul Cockrum, Thomas J.R. Beveridge, et al.. (2023). Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors. Journal of health economics and outcomes research. 121–131. 1 indexed citations
5.
Clarke, Callisia N., Paul Cockrum, Thomas J.R. Beveridge, et al.. (2023). Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors. Journal of health economics and outcomes research. 10(2). 121–131. 2 indexed citations
6.
Arcona, Steve, et al.. (2023). Work Loss and Direct and Indirect Costs Associated with Parkinson’s Disease. ClinicoEconomics and Outcomes Research. Volume 15. 309–319. 3 indexed citations
7.
Snider, Julia Thornton, et al.. (2022). Burden of Illness and Treatment Patterns in Second-line Large B-cell Lymphoma. Clinical Therapeutics. 44(4). 521–538. 2 indexed citations
8.
Silver, Jared, Néstor A. Molfino, Michael Bogart, et al.. (2021). Real-world impact of mepolizumab in patients with life-threatening asthma: US insurance claims database analysis. Clinical Therapeutics. 43(12). 2064–2073. 6 indexed citations
9.
Casale, Thomas B., Néstor A. Molfino, Jared Silver, et al.. (2021). Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities. Annals of Allergy Asthma & Immunology. 127(3). 354–362.e2. 26 indexed citations
10.
Silver, Jared, Michael Bogart, Elizabeth Packnett, et al.. (2020). <p>Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma</p>. Journal of Asthma and Allergy. Volume 13. 689–699. 18 indexed citations
11.
Bonafede, Machaon, Donna McMorrow, Virginia Noxon, et al.. (2020). Care Among Migraine Patients in a Commercially Insured Population. Neurology and Therapy. 9(1). 93–103. 8 indexed citations
12.
Gupta, Kiran, et al.. (2019). <p>Treatment patterns and economic outcomes in patients with juvenile idiopathic arthritis</p>. ClinicoEconomics and Outcomes Research. Volume 11. 361–371. 9 indexed citations
13.
Perales, Miguel‐Angel, Machaon Bonafede, Qian Cai, et al.. (2017). Real-World Economic Burden Associated with Transplantation-Related Complications. Biology of Blood and Marrow Transplantation. 23(10). 1788–1794. 10 indexed citations
14.
Bonafede, Machaon, Jeffrey R. Curtis, Donna McMorrow, Puneet Mahajan, & Chieh-I Chen. (2016). Treatment effectiveness and treatment patterns among rheumatoid arthritis patients after switching from a tumor necrosis factor inhibitor to another medication. ClinicoEconomics and Outcomes Research. Volume 8. 707–715. 26 indexed citations
15.
Mukherjee, Jayanti, Nancy Smith, Kelly Bell, et al.. (2016). Association Between Weight Change, Clinical Outcomes, and Health Care Costs in Patients with Type 2 Diabetes. Journal of Managed Care & Specialty Pharmacy. 22(5). 449–466. 10 indexed citations
16.
Montejano, Leslie, Lien Vo, & Donna McMorrow. (2015). Transitions of Care for People with Type 2 Diabetes: Utilization of Antihyperglycemic Agents Pre- and Post-Hospitalization. Diabetes Therapy. 7(1). 91–103. 14 indexed citations
17.
Johnston, Stephen S., Donna McMorrow, Amanda M. Farr, Paul Juneau, & Sarika Ogale. (2015). Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated with Infused Biologics After Switching from Another Biologic. Drugs - Real World Outcomes. 2(1). 99–109. 3 indexed citations
18.
19.
Landsman‐Blumberg, Pamela, et al.. (2014). Adherence and Persistence Among Chronic Myeloid Leukemia Patients During Second-Line Tyrosine Kinase Inhibitor Treatment. Journal of Managed Care Pharmacy. 20(10). 1006–1015. 30 indexed citations
20.
Zhao, Yang, Stephen S. Johnston, David M. Smith, et al.. (2013). Association between teriparatide adherence and healthcare utilization and costs among hip fracture patients in the United States. Bone. 60. 221–226. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Aguado Breakdown of academic impact, for papers by Nianwen Shi Breakdown of academic impact, for papers by M.L. te Winkel Breakdown of academic impact, for papers by Axel Svedbom Breakdown of academic impact, for papers by J. Timothy Harrington Breakdown of academic impact, for papers by Michele Intorcia Breakdown of academic impact, for papers by L. Pericleous Breakdown of academic impact, for papers by Ora Yadin Breakdown of academic impact, for papers by Rebecca Manno Breakdown of academic impact, for papers by Michael Schwarz-Eywill
Rankless by CCL
2026